ASX
Paradigm Biopharmaceuticals
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm Receives $5.75m R&D Tax Incentive Refund
Published: 22/07/26, 08:18am (AEST)•2 pages